FdaApplication
NDA 020144
Identifiers
- fda_app_no: NDA020144
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1996-02-27 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRANSDERM-NITRO | NITROGLYCERIN | 0.2MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FILM, EXTENDED RELEASE;TRANSDERMAL |
| TRANSDERM-NITRO | NITROGLYCERIN | 0.1MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FILM, EXTENDED RELEASE;TRANSDERMAL |
| TRANSDERM-NITRO | NITROGLYCERIN | 0.4MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FILM, EXTENDED RELEASE;TRANSDERMAL |
| TRANSDERM-NITRO | NITROGLYCERIN | 0.8MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FILM, EXTENDED RELEASE;TRANSDERMAL |
| TRANSDERM-NITRO | NITROGLYCERIN | 0.6MG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FILM, EXTENDED RELEASE;TRANSDERMAL |
5 products